CLOV vs TNXP
Clover Health Investments Corp (CLOV) versus Tonix Pharmaceuticals Holding Corp (TNXP) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Tonix Pharmaceuticals Holding Corp (TNXP) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported TNXP revenue for 2024-12-31 was $10.1M. Net income was -$130.0M. Revenue was up 29.9% from 2023-12-31 to 2024-12-31. TNXP currently screens at market cap $194.5M.
CLOV currently screens at market cap $1.55B. TNXP currently screens at market cap $194.5M.
Not investment advice. Open the CLOV and TNXP stock pages for the full models.
Not investment advice.